NDC codes

407817 NDC codes with hospital pricing data in the network.

• NDC 72572-0120-01 — DEXAMETHASONE SODIUM PHOSPHATE 4 MG/ML INJECTION SOLUTION (28 hospitals, 2,734–3,004 samples)
• NDC 63807060051 — HEPARIN LOCK FLUSH (PORCINE) (PF) 100 UNIT/ML INTRAVENOUS SYRINGE (42 hospitals, 2,301–3,003 samples)
• NDC 00409116301 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (182 hospitals, 1,633–3,001 samples)
• NDC 25021-0207-25 — DOXORUBICN 50MG/25MLSDV (74 hospitals, 2,902–3,001 samples)
• NDC 00942-0641-04 — DEXTROSE 2.45 GRAM-SOD CITRATE 2.2 GRAM-CITRIC AC 730 MG/100 ML SOLN (130 hospitals, 3,000 samples)
• NDC 00990-7111-09 — KCL-LACTATED RINGERS-D5W 20 MEQ/L IV SOLN (56 hospitals, 3,000 samples)
• NDC 00409-3150-05 — HEPARIN(PORCINE) IN 0.45% NACL 25,000 UNIT/500 ML IV SOLP|DISCARDED DRUG NOT ADMINISTE (32 hospitals, 3,000 samples)
• NDC 69374-0314-10 — MIDAZOLAM 100 MG/100 ML BOTTLE (38 hospitals, 2,647–2,998 samples)
• NDC 00904-7728-61 — CLONAZEPAM 1 MG TABLET (64 hospitals, 2,899–2,998 samples)
• NDC 42192-0608-06 — Gabapentin (58 hospitals, 2,899–2,998 samples)
• NDC 57664-0502-89 — tiZANidine 2mg tablet (54 hospitals, 2,899–2,998 samples)
• NDC 63739093114 — HEPARIN (PORCINE) 1000 UNIT/ML SOLUTION (103 hospitals, 402–2,994 samples)
• NDC 00409131236 — HYDROMORPHONE HCL INJ 2 MG/ML (127 hospitals, 915–2,994 samples)
• NDC 73070010310 — Insulin Aspart Soln Pen-injector 100 Unit/ML (91 hospitals, 1,184–2,993 samples)
• NDC 23155-0345-43 — PROPOFOL 10 MG/ML IV EMUL|DISCARDED DRUG NOT ADMINISTE (31 hospitals, 2,639–2,990 samples)
• NDC 63323-0285-67 — ROPIVACAINE (PF) 2 MG/ML (0.2%) EPIDURAL SOLUTION (35 hospitals, 2,899–2,989 samples)
• NDC 00409662902 — SUCCINYLCHOLINE SOLN-INJ 20 MG/ML 10 ML (241 hospitals, 1,593–2,988 samples)
• NDC 72572012025 — Dexamethasone Sodium Phosphate Inj 4 MG/ML,Dexamethasone Sodium Phosphate Inj 20 MG/5ML,Dexamethasone Sodium Phosphate Inj 120 MG/30ML,Dexamethasone Sodium Phosphate Inj Soln Pref Syr 4 MG/ML (118 hospitals, 2,132–2,987 samples)
• NDC 00069-4541-01 — INJECTION, DEXAMETHASONE SODIUM PHOSPHATE, 1 MG (10 hospitals, 2,545–2,986 samples)
• NDC 63323061400 — hydrALAZINE 20 mg/mL Soln 1 mL Vial (289 hospitals, 347–2,984 samples)
• NDC 00054-0742-87 — ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER (94 hospitals, 2,569–2,983 samples)
• NDC 73070010315 — Insulin Aspart Soln Pen-injector 100 Unit/ML (82 hospitals, 1,183–2,983 samples)
• NDC 409909425 — fentaNYL 250 mcg/5 mL Soln-Inj (158 hospitals, 2,402–2,978 samples)
• NDC 64253044425 — NDC Description Not Available (151 hospitals, 2,410–2,977 samples)
• NDC 67457056700 — INJ MAGNESIUM SULFATE 7003792 (85 hospitals, 1,536–2,976 samples)
• NDC 63807060005 — heparin flush 100 unit(s)/mL Soln-IV 5 mL (78 hospitals, 2,298–2,973 samples)
• NDC 47781058991 — 47781-0589-91 - midazolam 5 mg/mL Soln (82 hospitals, 1,368–2,970 samples)
• NDC 58160091252 — ARANESP (ALBUMIN FREE) 60 MCG/0.3ML IJ SOSY (38 hospitals, 2,878–2,968 samples)
• NDC 19515090452 — FLU VACCINE TS 2025-26(6MOS UP)(PF) 45 MCG(15MCG X3)/0.5 ML IM SYRINGE (77 hospitals, 2,878–2,968 samples)
• NDC 70004-0411-59 — MIDAZOLAM 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS (18 hospitals, 2,633–2,966 samples)
• NDC 70092-1418-36 — MIDAZOLAM (PF) IN 0.9 % NACL 1 MG/ML IV SOLN (61 hospitals, 2,633–2,966 samples)
• NDC 70860040541 — BUMETANIDE 0.25 MG/ML IJ SOLN (124 hospitals, 842–2,966 samples)
• NDC 72205010101 — BUMETANIDE 0.25 MG/ML INJECTION SOLUTION (139 hospitals, 842–2,966 samples)
• NDC 33332002504 — Afluria 2025-2026 Formula PFS (49 hospitals, 2,877–2,958 samples)
• NDC 33332002503 — AFLURIA PRESERVATIVE FREE 0.5 ML IM SUSY (11 hospitals, 2,877–2,958 samples)
• NDC 68462075601 — ketorolac 30 MG/ML Soln 1 mL Vial (85 hospitals, 967–2,956 samples)
• NDC 71288-0806-51 — ZOLEDRONIC ACID 5 MG/100 ML IN MANNITOL 5 %-WATER INTRAVENOUS PIGGYBCK (68 hospitals, 2,834–2,951 samples)
• NDC 00990798355 — SODIUM CHLORIDE 0.9% 0.9 % SOLUTION 500 ML FLEX CONT (66 hospitals, 1,367–2,942 samples)
• NDC 65219022401 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (NON-PVC) (30 hospitals, 1,367–2,942 samples)
• NDC 70092-1380-36 — MORPHINE (PF) 1 MG/ML IN 0.9% SODIUM CHLORIDE INTRAVENOUS SOLUTION (100 hospitals, 2,743–2,941 samples)
• NDC 63323085115 — HYDROMORPHONE HCL PF 10 MG/ML IJ SOLN|DISCARDED DRUG NOT ADMINISTERED (97 hospitals, 978–2,940 samples)
• NDC 38779-1756-09 — FENTANYL CITRATE N/A POWD (5 hospitals, 2,938 samples)
• NDC 00000-0009-16 — MISOPROSTOL 25 MCG SPLIT TABLET (2 hospitals, 2,938 samples)
• NDC 00000-0010-24 — FENTANYL CITRATE (PF) 100 MCG/2ML INJ SOLN (2 hospitals, 2,938 samples)
• NDC 72333-2002-00 — FENTANYL 50 MCG/ML 25 ML PEDS INFUSION SYRINGE (1 hospital, 2,938 samples)
• NDC 00000-0009-15 — MISOPROSTOL 50 MCG SPLIT TABLET (5 hospitals, 2,938 samples)
• NDC 25021010010 — ceFAZolin 500 mg Injection (116 hospitals, 1,029–2,937 samples)
• NDC 409909422 — fentaNYL 100 mcg/2 mL Soln-Inj (164 hospitals, 2,423–2,936 samples)
• NDC 6332345400 — MORPHINE 4 MG/ML INJECTION SOLUTION (30 hospitals, 317–2,936 samples)
• NDC 6332345401 — MORPHINE 4 MG/ML INJECTION SOLUTION (45 hospitals, 317–2,936 samples)